nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethambutol—Optic neuritis—Doxorubicin—pancreatic cancer	0.00455	0.00455	CcSEcCtD
Ethambutol—Visual impairment—Tamoxifen—pancreatic cancer	0.00445	0.00445	CcSEcCtD
Ethambutol—Pneumonia—Sunitinib—pancreatic cancer	0.00443	0.00443	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00437	0.00437	CcSEcCtD
Ethambutol—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00437	0.00437	CcSEcCtD
Ethambutol—Erythema multiforme—Erlotinib—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Ethambutol—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Ethambutol—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.00424	0.00424	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Ethambutol—Neuritis—Epirubicin—pancreatic cancer	0.00405	0.00405	CcSEcCtD
Ethambutol—Scotoma—Epirubicin—pancreatic cancer	0.00398	0.00398	CcSEcCtD
Ethambutol—Hepatitis—Sunitinib—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Ethambutol—Hypoaesthesia—Sunitinib—pancreatic cancer	0.00394	0.00394	CcSEcCtD
Ethambutol—Eosinophilia—Fluorouracil—pancreatic cancer	0.00386	0.00386	CcSEcCtD
Ethambutol—Neutropenia—Irinotecan—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Ethambutol—Neuritis—Doxorubicin—pancreatic cancer	0.00375	0.00375	CcSEcCtD
Ethambutol—Erythema multiforme—Sunitinib—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Ethambutol—Neutropenia—Gemcitabine—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Ethambutol—Scotoma—Doxorubicin—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Ethambutol—Pneumonia—Irinotecan—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Ethambutol—Leukopenia—Tamoxifen—pancreatic cancer	0.0036	0.0036	CcSEcCtD
Ethambutol—Pneumonia—Gemcitabine—pancreatic cancer	0.00356	0.00356	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Ethambutol—Pneumonia—Fluorouracil—pancreatic cancer	0.0035	0.0035	CcSEcCtD
Ethambutol—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00347	0.00347	CcSEcCtD
Ethambutol—Arthralgia—Tamoxifen—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Ethambutol—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00341	0.00341	CcSEcCtD
Ethambutol—Arthralgia—Erlotinib—pancreatic cancer	0.00339	0.00339	CcSEcCtD
Ethambutol—Discomfort—Tamoxifen—pancreatic cancer	0.00338	0.00338	CcSEcCtD
Ethambutol—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Ethambutol—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Ethambutol—Visual impairment—Irinotecan—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Ethambutol—Anorexia—Tamoxifen—pancreatic cancer	0.00313	0.00313	CcSEcCtD
Ethambutol—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Ethambutol—Anorexia—Erlotinib—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Ethambutol—Leukopenia—Sunitinib—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Ethambutol—Liver function test abnormal—Docetaxel—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Ethambutol—Erythema multiforme—Gemcitabine—pancreatic cancer	0.003	0.003	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Ethambutol—Paraesthesia—Tamoxifen—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Ethambutol—Arthralgia—Sunitinib—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Ethambutol—Decreased appetite—Tamoxifen—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Ethambutol—Decreased appetite—Erlotinib—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Ethambutol—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Ethambutol—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Ethambutol—Anorexia—Sunitinib—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Ethambutol—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Ethambutol—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Ethambutol—Neutropenia—Docetaxel—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Ethambutol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Ethambutol—Lymphadenopathy—Epirubicin—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Ethambutol—Abdominal pain—Erlotinib—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Ethambutol—Body temperature increased—Erlotinib—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Ethambutol—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Ethambutol—Vision blurred—Fluorouracil—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Ethambutol—Malaise—Irinotecan—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Ethambutol—Leukopenia—Irinotecan—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Ethambutol—Pneumonia—Docetaxel—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Ethambutol—Paraesthesia—Sunitinib—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Ethambutol—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Ethambutol—Malaise—Gemcitabine—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Ethambutol—Leukopenia—Gemcitabine—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Ethambutol—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Ethambutol—Decreased appetite—Sunitinib—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Ethambutol—Leukopenia—Fluorouracil—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Ethambutol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Ethambutol—Discomfort—Irinotecan—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Ethambutol—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Ethambutol—Arthralgia—Gemcitabine—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Ethambutol—Confusional state—Irinotecan—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Ethambutol—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Ethambutol—Discomfort—Gemcitabine—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Ethambutol—Pruritus—Tamoxifen—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Ethambutol—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Ethambutol—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Ethambutol—Pruritus—Erlotinib—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Ethambutol—Discomfort—Fluorouracil—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Ethambutol—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Ethambutol—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Ethambutol—Hepatitis—Docetaxel—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Ethambutol—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Ethambutol—Confusional state—Fluorouracil—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Ethambutol—Body temperature increased—Sunitinib—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Ethambutol—Abdominal pain—Sunitinib—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Ethambutol—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Ethambutol—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Ethambutol—Anorexia—Irinotecan—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Ethambutol—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Ethambutol—Visual impairment—Docetaxel—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Ethambutol—Dizziness—Tamoxifen—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Ethambutol—Anorexia—Gemcitabine—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Ethambutol—Dizziness—Erlotinib—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Ethambutol—Erythema multiforme—Docetaxel—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Ethambutol—Anorexia—Fluorouracil—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Ethambutol—Vomiting—Tamoxifen—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Ethambutol—Paraesthesia—Irinotecan—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Ethambutol—Hypersensitivity—Sunitinib—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Ethambutol—Rash—Tamoxifen—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Ethambutol—Dermatitis—Tamoxifen—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Ethambutol—Vomiting—Erlotinib—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Ethambutol—Headache—Tamoxifen—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Ethambutol—Rash—Erlotinib—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Ethambutol—Dermatitis—Erlotinib—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Ethambutol—Headache—Erlotinib—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Ethambutol—Liver function test abnormal—Epirubicin—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Ethambutol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Ethambutol—Decreased appetite—Irinotecan—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ethambutol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Ethambutol—Pruritus—Sunitinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Ethambutol—Decreased appetite—Gemcitabine—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Ethambutol—Nausea—Tamoxifen—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Ethambutol—Nausea—Erlotinib—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Ethambutol—Decreased appetite—Fluorouracil—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Ethambutol—Feeling abnormal—Irinotecan—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Ethambutol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Ethambutol—Eosinophilia—Epirubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Ethambutol—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Ethambutol—Dizziness—Sunitinib—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Ethambutol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Ethambutol—Body temperature increased—Irinotecan—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Ethambutol—Abdominal pain—Irinotecan—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Ethambutol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Ethambutol—Vomiting—Sunitinib—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Ethambutol—Body temperature increased—Gemcitabine—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Ethambutol—Neutropenia—Epirubicin—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Ethambutol—Rash—Sunitinib—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Ethambutol—Dermatitis—Sunitinib—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Ethambutol—Headache—Sunitinib—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Ethambutol—Leukopenia—Docetaxel—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Ethambutol—Body temperature increased—Fluorouracil—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Ethambutol—Eosinophilia—Doxorubicin—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Ethambutol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Ethambutol—Pneumonia—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ethambutol—Arthralgia—Docetaxel—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Ethambutol—Nausea—Sunitinib—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Ethambutol—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Ethambutol—Neutropenia—Doxorubicin—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Ethambutol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Ethambutol—Confusional state—Docetaxel—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Ethambutol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Ethambutol—Pruritus—Gemcitabine—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Ethambutol—Pneumonia—Doxorubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Ethambutol—Pruritus—Fluorouracil—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Ethambutol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Ethambutol—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Ethambutol—Dizziness—Irinotecan—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Ethambutol—Anorexia—Docetaxel—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Ethambutol—Hepatitis—Epirubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Ethambutol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Ethambutol—Vomiting—Irinotecan—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Ethambutol—Dizziness—Fluorouracil—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Ethambutol—Visual impairment—Epirubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Ethambutol—Rash—Irinotecan—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Ethambutol—Dermatitis—Irinotecan—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Ethambutol—Headache—Irinotecan—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Ethambutol—Paraesthesia—Docetaxel—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Ethambutol—Erythema multiforme—Epirubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Ethambutol—Vomiting—Gemcitabine—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Ethambutol—Rash—Gemcitabine—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ethambutol—Dermatitis—Gemcitabine—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ethambutol—Headache—Gemcitabine—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Ethambutol—Vomiting—Fluorouracil—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Ethambutol—Hepatitis—Doxorubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Ethambutol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Ethambutol—Rash—Fluorouracil—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Ethambutol—Dermatitis—Fluorouracil—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Ethambutol—Decreased appetite—Docetaxel—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Ethambutol—Headache—Fluorouracil—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Ethambutol—Nausea—Irinotecan—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Ethambutol—Visual impairment—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Ethambutol—Nausea—Gemcitabine—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Ethambutol—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Ethambutol—Feeling abnormal—Docetaxel—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Ethambutol—Nausea—Fluorouracil—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Ethambutol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Ethambutol—Abdominal pain—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Ethambutol—Body temperature increased—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Ethambutol—Vision blurred—Epirubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Ethambutol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Ethambutol—Malaise—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Ethambutol—Leukopenia—Epirubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Ethambutol—Hypersensitivity—Docetaxel—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Ethambutol—Vision blurred—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Ethambutol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Ethambutol—Pruritus—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Ethambutol—Arthralgia—Epirubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Ethambutol—Discomfort—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Ethambutol—Malaise—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Ethambutol—Leukopenia—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Ethambutol—Confusional state—Epirubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Ethambutol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Ethambutol—Dizziness—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Ethambutol—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Ethambutol—Arthralgia—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Ethambutol—Discomfort—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Ethambutol—Anorexia—Epirubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Ethambutol—Vomiting—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Ethambutol—Rash—Docetaxel—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Ethambutol—Dermatitis—Docetaxel—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Ethambutol—Confusional state—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Ethambutol—Headache—Docetaxel—pancreatic cancer	0.001	0.001	CcSEcCtD
Ethambutol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000999	0.000999	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000983	0.000983	CcSEcCtD
Ethambutol—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000978	0.000978	CcSEcCtD
Ethambutol—Paraesthesia—Epirubicin—pancreatic cancer	0.000969	0.000969	CcSEcCtD
Ethambutol—Anorexia—Doxorubicin—pancreatic cancer	0.000952	0.000952	CcSEcCtD
Ethambutol—Nausea—Docetaxel—pancreatic cancer	0.000951	0.000951	CcSEcCtD
Ethambutol—Decreased appetite—Epirubicin—pancreatic cancer	0.000938	0.000938	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00091	0.00091	CcSEcCtD
Ethambutol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000897	0.000897	CcSEcCtD
Ethambutol—Feeling abnormal—Epirubicin—pancreatic cancer	0.00089	0.00089	CcSEcCtD
Ethambutol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000883	0.000883	CcSEcCtD
Ethambutol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000868	0.000868	CcSEcCtD
Ethambutol—Body temperature increased—Epirubicin—pancreatic cancer	0.000853	0.000853	CcSEcCtD
Ethambutol—Abdominal pain—Epirubicin—pancreatic cancer	0.000853	0.000853	CcSEcCtD
Ethambutol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000823	0.000823	CcSEcCtD
Ethambutol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000817	0.000817	CcSEcCtD
Ethambutol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000795	0.000795	CcSEcCtD
Ethambutol—Abdominal pain—Doxorubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Ethambutol—Body temperature increased—Doxorubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Ethambutol—Pruritus—Epirubicin—pancreatic cancer	0.000764	0.000764	CcSEcCtD
Ethambutol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Ethambutol—Dizziness—Epirubicin—pancreatic cancer	0.000714	0.000714	CcSEcCtD
Ethambutol—Pruritus—Doxorubicin—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Ethambutol—Vomiting—Epirubicin—pancreatic cancer	0.000686	0.000686	CcSEcCtD
Ethambutol—Rash—Epirubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Ethambutol—Dermatitis—Epirubicin—pancreatic cancer	0.00068	0.00068	CcSEcCtD
Ethambutol—Headache—Epirubicin—pancreatic cancer	0.000676	0.000676	CcSEcCtD
Ethambutol—Dizziness—Doxorubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Ethambutol—Nausea—Epirubicin—pancreatic cancer	0.000641	0.000641	CcSEcCtD
Ethambutol—Vomiting—Doxorubicin—pancreatic cancer	0.000635	0.000635	CcSEcCtD
Ethambutol—Rash—Doxorubicin—pancreatic cancer	0.00063	0.00063	CcSEcCtD
Ethambutol—Dermatitis—Doxorubicin—pancreatic cancer	0.000629	0.000629	CcSEcCtD
Ethambutol—Headache—Doxorubicin—pancreatic cancer	0.000626	0.000626	CcSEcCtD
Ethambutol—Nausea—Doxorubicin—pancreatic cancer	0.000593	0.000593	CcSEcCtD
